Susceptibility of Streptococcus mutans to antimicrobial agents

Area of Science:

• Microbiology
• Pharmacology

Background:

• Streptococcus mutans is a primary pathogen in dental caries.
• Understanding antimicrobial susceptibility is crucial for effective treatment and prevention strategies.

Purpose of the Study:

• To evaluate the in vitro susceptibility of Streptococcus mutans strains to a panel of 20 antimicrobial agents.
• To identify antibiotics with significant inhibitory activity against Streptococcus mutans.

Main Methods:

• Testing of fifty Streptococcus mutans strains (defined and clinical isolates).
• Determination of Minimal Inhibitory Concentrations (MICs) using a liquid microtiter procedure.
• Assessment against 20 different antimicrobial agents.

Main Results:

• Penicillin, ampicillin, erythromycin, cephalothin, and methicillin were highly effective at concentrations below 0.1 µg/ml.
• Rifampin, lincomycin, vancomycin, tetracycline, and chloramphenicol showed efficacy between 0.1 and 10 µg/ml.
• Aminoglycosides like kanamycin and streptomycin required higher concentrations (10-400 µg/ml). Tetracycline, thiostrepton, and spiromycin exhibited a broad 1,000-fold effective concentration range.

Conclusions:

• Significant variability exists in Streptococcus mutans susceptibility to various antimicrobial agents.
• Certain antibiotics, including penicillin and erythromycin, demonstrate potent activity against Streptococcus mutans.
• Findings provide insights into potential therapeutic options and resistance monitoring for managing Streptococcus mutans infections.